Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

12.97

+0.80 (6.57%)

At close: Nov 6, 2026, 4:00 PM EST

13.41

+0.44 (3.39%)

Pre-market: Nov 9, 2026, 7:55 AM EST

Kailera Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-379.49	-158.34	-24.52
Net Income	-348.24	-148.96	-329.57
Earnings Per Share	-2.69	-7819.98	-
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,038	652.73	175.18
Total Debt	9.97	10.75	0.51
Net Cash (Debt)	1,028	641.98	174.67
Net Cash Growth	488.35%	267.54%	-
Net Cash Per Share	7.92	33703.01	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-325.59	-120.21	-184.95
Capital Expenditures	-1.65	-2.09	-0.39
Free Cash Flow	-327.23	-122.3	-185.35
Free Cash Flow Growth	-	-	-